FDA Approves Second Ustekinumab Biosimilar FDA Approves Second Ustekinumab Biosimilar

The biosimilar is expected to be marketed in the United States on or after February 21, 2025.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology News Alert Source Type: news